ALPS Advisors’s Viking Therapeutics VKTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.61M | Buy |
+60,629
| New | +$1.61M | 0.01% | 398 |
|
|
2024
Q2 | – | Sell |
-74,007
| Closed | -$6.07M | – | 1006 |
|
|
2024
Q1 | $6.07M | Buy |
74,007
+7,630
| +11% | +$626K | 0.04% | 213 |
|
|
2023
Q4 | $1.24M | Sell |
66,377
-7,428
| -10% | -$138K | 0.01% | 418 |
|
|
2023
Q3 | $817K | Buy |
73,805
+418
| +0.6% | +$4.63K | 0.01% | 513 |
|
|
2023
Q2 | $1.19M | Buy |
73,387
+21,669
| +42% | +$351K | 0.01% | 432 |
|
|
2023
Q1 | $861K | Sell |
51,718
-325
| -0.6% | -$5.41K | 0.01% | 501 |
|
|
2022
Q4 | $489K | Buy |
+52,043
| New | +$489K | ﹤0.01% | 596 |
|
|
2022
Q2 | – | Sell |
-80,540
| Closed | -$242K | – | 1093 |
|
|
2022
Q1 | $242K | Sell |
80,540
-9,999
| -11% | -$30K | ﹤0.01% | 792 |
|
|
2021
Q4 | $416K | Sell |
90,539
-5,296
| -6% | -$24.3K | ﹤0.01% | 620 |
|
|
2021
Q3 | $602K | Sell |
95,835
-7,030
| -7% | -$44.2K | 0.01% | 479 |
|
|
2021
Q2 | $616K | Sell |
102,865
-29,113
| -22% | -$174K | 0.01% | 493 |
|
|
2021
Q1 | $835K | Buy |
131,978
+469
| +0.4% | +$2.97K | 0.01% | 420 |
|
|
2020
Q4 | $740K | Buy |
131,509
+38,719
| +42% | +$218K | 0.01% | 423 |
|
|
2020
Q3 | $540K | Sell |
92,790
-6,237
| -6% | -$36.3K | 0.01% | 415 |
|
|
2020
Q2 | $714K | Sell |
99,027
-32,351
| -25% | -$233K | 0.01% | 385 |
|
|
2020
Q1 | $615K | Sell |
131,378
-15,322
| -10% | -$71.7K | 0.01% | 409 |
|
|
2019
Q4 | $1.18M | Buy |
146,700
+2,681
| +2% | +$21.5K | 0.01% | 307 |
|
|
2019
Q3 | $991K | Sell |
144,019
-6,791
| -5% | -$46.7K | 0.01% | 314 |
|
|
2019
Q2 | $1.25M | Sell |
150,810
-21,793
| -13% | -$181K | 0.01% | 285 |
|
|
2019
Q1 | $1.72M | Buy |
172,603
+7,458
| +5% | +$74.1K | 0.01% | 245 |
|
|
2018
Q4 | $1.26M | Buy |
+165,145
| New | +$1.26M | 0.01% | 256 |
|